Latest Research, Industry, Medical and Scientific News
Urinary incontinence (UI), the involuntary leakage of urine, is a frequent and problematic chronic condition for many patients. An estimated 10 to 30% of men and women are affected nationally, though this may be underestimated due to underdiagnoses and undertreatment.1-3 Often, patients who suffer with UI symptoms will develop poor self-rated health, depression, and mobility disability.4,5 This comorbid disease state also presents a substantial financial burden; data from 2014 found that in the United States alone, an estimated $65.9 billion in direct and indirect costs were spent for UI treatment.3 Read more.
Source: Drug Topics, January 23, 2018
It is fairly common to think of constipation in a humorous light. However, anyone who has suffered from the debilitating condition can attest that it is far from a laughing matter. With a sizable percentage of the population increasing in age and opioid abuse reaching epidemic proportions, investigators are looking for new tools to help patients ease their gastrointestinal suffering. Now, investigators from Thomas Jefferson University (TJU) have just released data of a new technique—called magnetofection—that incorporates micro-metal beads coated with small RNA fragments (microRNAs, or miRNAs) injected at specific regions of the colon and held in place with a powerful magnet. Read more.
Source: Genetic Engineering and Biotechnology News, January 17, 2018
A drug used to curtail episodes of urinary incontinence in women also improves quality of sleep, a researcher at the Stanford University School of Medicine reports. People who experience urinary incontinence, especially at night, often have trouble maintaining normal sleep cycles. Now, the Stanford researcher sees promise in using one drug to help remedy both problems. “Two of the biggest quality-of-life factors for older women are poor sleep quality and incontinence, and the older you get, the more prevalent both conditions are, and they do seem to be correlated,” said Leslee Subak, MD, professor and chair of obstetrics and gynecology. “And so, if we can find a drug to treat one and effectively decrease the other too, that could be big for improving quality of life.” Read more.
Source: Stanford Medicine News Center, January 11, 2018
You may also with to read: Incontinence Drug May Help Sleep Dysfunction in Older Women
Elidah (http://www.elidah.com) has received multiple awards for further development of its neuromuscular stimulation technology to treat incontinence. Elidah has received a grant from the National Science Foundation (NSF) to continue development of its wearable device, Elitone, designed to treat urinary incontinence, a condition that affects one in three women. Additionally, the Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Program in the Department of Defense (DoD) has awarded Elidah a contract to develop and adapt the Elitone technology for the treatment of injured Service members. These awards start in January 2018. Read more.
Source: NBHerard, January 9, 2018
The San Francisco Bay Area may be best known for information technology startups, but there are other small companies around that develop very different technologies. CompactCath has created a urinary catheter that solves some of the persistent issues that users of such devices have to face every day, and the company just announced that its eponymous device received CE Mark approval in Europe. About a year ago the CompactCath received FDA clearance. Read more.
Source: Medgadget, December 13, 2017
Hormone therapies in menopausal women are associated with some beneficial effects, such as decreased risk for diabetes and fracture, but are also associated with increased risks for stroke, thromboembolic events, gallbladder disease and urinary incontinence, according to an evidence report and systematic review for the U.S. Preventive Services Task Force. In 2012, the USPSTF recommended against the use of HT for prevention of chronic conditions, and the current update continues to recommend against its use. Read more.
Source: Healio, December 12, 2017